LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 78

Search options

  1. Article ; Online: Morphological Effects and In Vitro Biological Mechanisms of Radiation-Induced Cell Killing by Gold Nanomaterials.

    Jenkins, Samir V / Jung, Seunghyun / Jamshidi-Parsian, Azemat / Borrelli, Michael J / Dings, Ruud P M / Griffin, Robert J

    ACS applied materials & interfaces

    2023  Volume 15, Issue 50, Page(s) 58241–58250

    Abstract: Gold nanomaterials have been shown to augment radiation therapy both in vitro and in vivo. However, studies on these materials are mostly phenomenological due to nanoparticle heterogeneity and the complexity of biological systems. Even accurate ... ...

    Abstract Gold nanomaterials have been shown to augment radiation therapy both in vitro and in vivo. However, studies on these materials are mostly phenomenological due to nanoparticle heterogeneity and the complexity of biological systems. Even accurate quantification of the particle dose still results in bulk average biases; the effect on individual cells is not measured but rather the effect on the overall population. To perform quantitative nanobiology, we coated glass coverslips uniformly at varying densities with Au nanoparticle preparations with different morphologies (45 nm cages, 25 nm spheres, and 30 nm rods). Consequently, the effect of a specific number of particles per unit area in contact with breast cancer cells growing on the coated surfaces was ascertained. Gold nanocages showed the highest degree of radiosensitization on a per particle basis, followed by gold nanospheres and gold nanorods, respectively. All three materials showed little cytotoxic effect at 0 Gy, but clonogenic survival decreased proportionally with the radiation dose and particle coverage density. A similar trend was seen in vivo in the combined treatment antitumor response in 4T1 tumor-bearing animals. The presence of gold affected the type and quantity of reactive oxygen species generated, specifically superoxide and hydroxyl radicals, and the concentration of nanocages correlated with the development of more numerous double-stranded DNA breaks and increased protein oxidation as measured by carbonylation. This work demonstrates the dependence on morphology and concentration of radiation enhancement by gold nanomaterials and may lead to a novel method to differentiate intra- and extracellular functionalities of gold nanomedicine treatment strategies. It further provides insights that can guide the rational development of gold nanomaterial-based radiosensitizers for clinical use.
    MeSH term(s) Animals ; Gold/pharmacology ; Gold/metabolism ; Metal Nanoparticles ; Apoptosis ; Nanostructures ; Radiation-Sensitizing Agents/pharmacology
    Chemical Substances Gold (7440-57-5) ; Radiation-Sensitizing Agents
    Language English
    Publishing date 2023-12-07
    Publishing country United States
    Document type Journal Article
    ISSN 1944-8252
    ISSN (online) 1944-8252
    DOI 10.1021/acsami.3c15358
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Acquired Radiation Resistance Induces Thiol-dependent Cisplatin Cross-resistance.

    Jenkins, Samir V / Shah, Shruti / Jamshidi-Parsian, Azemat / Mortazavi, Amir / Kristian, Hailey / Boysen, Gunnar / Vang, Kieng B / Griffin, Robert J / Rajaram, Narasimhan / Dings, Ruud P M

    Radiation research

    2024  Volume 201, Issue 2, Page(s) 174–187

    Abstract: Resistance to radiation remains a significant clinical challenge in non-small cell lung carcinoma (NSCLC). It is therefore important to identify the underlying molecular and cellular features that drive acquired resistance. We generated genetically ... ...

    Abstract Resistance to radiation remains a significant clinical challenge in non-small cell lung carcinoma (NSCLC). It is therefore important to identify the underlying molecular and cellular features that drive acquired resistance. We generated genetically matched NSCLC cell lines to investigate characteristics of acquired resistance. Murine Lewis lung carcinoma (LLC) and human A549 cells acquired an approximate 1.5-2.5-fold increase in radiation resistance as compared to their parental match, which each had unique intrinsic radio-sensitivities. The radiation resistance (RR) was reflected in higher levels of DNA damage and repair marker γH2AX and reduced apoptosis induction after radiation. Morphologically, we found that radiation resistance A549 (A549-RR) cells exhibited a greater nucleus-to-cytosol (N/C) ratio as compared to its parental counterpart. Since the N/C ratio is linked to the differentiation state, we next investigated the epithelial-to-mesenchymal transition (EMT) phenotype and cellular plasticity. We found that A549 cells had a greater radiation-induced plasticity, as measured by E-cadherin, vimentin and double-positive (DP) modulation, as compared to LLC. Additionally, migration was suppressed in A549-RR cells, as compared to A549 cells. Subsequently, we confirmed in vivo that the LLC-RR and A549-RR cells are also more resistance to radiation than their isogenic-matched counterpart. Moreover, we found that the acquired radiation resistance also induced resistance to cisplatin, but not carboplatin or oxaliplatin. This cross-resistance was attributed to induced elevation of thiol levels. Gamma-glutamylcysteine synthetase inhibitor buthionine sulfoximine (BSO) sensitized the resistant cells to cisplatin by decreasing the amount of thiols to levels prior to obtaining acquired radiation resistance. By generating radiation-resistance genetically matched NSCLC we were able to identify and overcome cisplatin cross-resistance. This is an important finding arguing for combinatorial treatment regimens including glutathione pathway disruptors in patients with the potential of improving clinical outcomes in the future.
    MeSH term(s) Humans ; Animals ; Mice ; Cisplatin/pharmacology ; Cisplatin/therapeutic use ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/radiotherapy ; Carboplatin ; Buthionine Sulfoximine/pharmacology ; Buthionine Sulfoximine/therapeutic use ; Lung Neoplasms/genetics ; Lung Neoplasms/radiotherapy ; Drug Resistance, Neoplasm/genetics ; Cell Line, Tumor
    Chemical Substances Cisplatin (Q20Q21Q62J) ; Antineoplastic Agents ; Carboplatin (BG3F62OND5) ; Buthionine Sulfoximine (5072-26-4)
    Language English
    Publishing date 2024-02-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80322-4
    ISSN 1938-5404 ; 0033-7587
    ISSN (online) 1938-5404
    ISSN 0033-7587
    DOI 10.1667/RADE-23-00005.1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Simulating cellular galectin networks by mixing galectins in vitro reveals synergistic activity.

    Dings, Ruud P M / Kumar, Nigam / Mikkelson, Sterling / Gabius, Hans-Joachim / Mayo, Kevin H

    Biochemistry and biophysics reports

    2021  Volume 28, Page(s) 101116

    Abstract: Background: Even though members of the family of adhesion/growth-regulatory galectins are increasingly detected to be co-expressed, they are still being routinely tested separately. The recent discovery of heterodimer formation among galectins-1, -3, ... ...

    Abstract Background: Even though members of the family of adhesion/growth-regulatory galectins are increasingly detected to be co-expressed, they are still being routinely tested separately. The recent discovery of heterodimer formation among galectins-1, -3, and -7 in mixtures prompts further study of their functional activities in mixtures.
    Methods: Cell agglutination, galectin binding to cells, as well as effects on cell proliferation, onset of apoptosis and migration were determined in assays using various cell types and mixtures of galectins-1, -3, and -7.
    Results: Evidence for a more than additive increases of experimental parameters was consistently obtained.
    Conclusion: Testing galectins in mixtures simulates the situation of co-expression
    Language English
    Publishing date 2021-08-28
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2831046-9
    ISSN 2405-5808 ; 2405-5808
    ISSN (online) 2405-5808
    ISSN 2405-5808
    DOI 10.1016/j.bbrep.2021.101116
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Further rationale for optimal combined modality treatments.

    Griffin, Robert J / Dings, Ruud P M / Makhoul, Issam

    Oncotarget

    2017  Volume 8, Issue 16, Page(s) 25831–25832

    MeSH term(s) Combined Modality Therapy ; Humans ; Neoplasms
    Language English
    Publishing date 2017-04-13
    Publishing country United States
    Document type News ; Comment
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.16117
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Simulating cellular galectin networks by mixing galectins in vitro reveals synergistic activity

    Ruud P.M. Dings / Nigam Kumar / Sterling Mikkelson / Hans-Joachim Gabius / Kevin H. Mayo

    Biochemistry and Biophysics Reports, Vol 28, Iss , Pp 101116- (2021)

    2021  

    Abstract: Background: Even though members of the family of adhesion/growth-regulatory galectins are increasingly detected to be co-expressed, they are still being routinely tested separately. The recent discovery of heterodimer formation among galectins-1, -3, and ...

    Abstract Background: Even though members of the family of adhesion/growth-regulatory galectins are increasingly detected to be co-expressed, they are still being routinely tested separately. The recent discovery of heterodimer formation among galectins-1, -3, and -7 in mixtures prompts further study of their functional activities in mixtures. Methods: Cell agglutination, galectin binding to cells, as well as effects on cell proliferation, onset of apoptosis and migration were determined in assays using various cell types and mixtures of galectins-1, -3, and -7. Results: Evidence for a more than additive increases of experimental parameters was consistently obtained. Conclusion: Testing galectins in mixtures simulates the situation of co-expression in situ and reveals unsuspected over-additive activities. This new insight is relevant for analyzing galectin functionality in (patho)physiological conditions.
    Keywords Adhesion ; Agglutinin ; Apoptosis ; Lectin ; Migration ; Biology (General) ; QH301-705.5 ; Biochemistry ; QD415-436
    Language English
    Publishing date 2021-12-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models.

    Koonce, Nathan A / Griffin, Robert J / Dings, Ruud P M

    International journal of molecular sciences

    2017  Volume 18, Issue 12

    Abstract: Galectin-1 is a hypoxia-regulated protein and a prognostic marker in head and neck squamous cell carcinomas (HNSCC). Here we assessed the ability of non-peptidic galectin-1 inhibitor OTX008 to improve tumor oxygenation levels via tumor vessel ... ...

    Abstract Galectin-1 is a hypoxia-regulated protein and a prognostic marker in head and neck squamous cell carcinomas (HNSCC). Here we assessed the ability of non-peptidic galectin-1 inhibitor OTX008 to improve tumor oxygenation levels via tumor vessel normalization as well as tumor growth inhibition in two human HNSCC tumor models, the human laryngeal squamous carcinoma SQ20B and the human epithelial type 2 HEp-2. Tumor-bearing mice were treated with OTX008, Anginex, or Avastin and oxygen levels were determined by fiber-optics and molecular marker pimonidazole binding. Immuno-fluorescence was used to determine vessel normalization status. Continued OTX008 treatment caused a transient reoxygenation in SQ20B tumors peaking on day 14, while a steady increase in tumor oxygenation was observed over 21 days in the HEp-2 model. A >50% decrease in immunohistochemical staining for tumor hypoxia verified the oxygenation data measured using a partial pressure of oxygen (pO₂) probe. Additionally, OTX008 induced tumor vessel normalization as tumor pericyte coverage increased by approximately 40% without inducing any toxicity. Moreover, OTX008 inhibited tumor growth as effectively as Anginex and Avastin, except in the HEp-2 model where Avastin was found to suspend tumor growth. Galectin-1 inhibitor OTX008 transiently increased overall tumor oxygenation via vessel normalization to various degrees in both HNSCC models. These findings suggest that targeting galectin-1-e.g., by OTX008-may be an effective approach to treat cancer patients as stand-alone therapy or in combination with other standards of care.
    MeSH term(s) Angiogenesis Inhibitors/administration & dosage ; Angiogenesis Inhibitors/pharmacology ; Animals ; Bevacizumab/administration & dosage ; Bevacizumab/pharmacology ; Calixarenes/administration & dosage ; Calixarenes/pharmacology ; Carcinoma, Squamous Cell/blood supply ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/metabolism ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Galectin 1/antagonists & inhibitors ; Head and Neck Neoplasms/blood supply ; Head and Neck Neoplasms/drug therapy ; Head and Neck Neoplasms/metabolism ; Humans ; Mice ; Oxygen/metabolism ; Peptides/administration & dosage ; Peptides/pharmacology ; Squamous Cell Carcinoma of Head and Neck ; Xenograft Model Antitumor Assays
    Chemical Substances Angiogenesis Inhibitors ; Galectin 1 ; LGALS1 protein, human ; Peptides ; anginex peptide ; compound 0118 ; Calixarenes (130036-26-9) ; Bevacizumab (2S9ZZM9Q9V) ; Oxygen (S88TT14065)
    Language English
    Publishing date 2017-12-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms18122671
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Spectroscopic investigation of radiation-induced reoxygenation in radiation-resistant tumors.

    Dadgar, Sina / Troncoso, Joel Rodriguez / Siegel, Eric R / Curry, Natalie M / Griffin, Robert J / Dings, Ruud P M / Rajaram, Narasimhan

    Neoplasia (New York, N.Y.)

    2020  Volume 23, Issue 1, Page(s) 49–57

    Abstract: Fractionated radiation therapy is believed to reoxygenate and subsequently radiosensitize surviving hypoxic cancer cells. Measuring tumor reoxygenation between radiation fractions could conceivably provide an early biomarker of treatment response. ... ...

    Abstract Fractionated radiation therapy is believed to reoxygenate and subsequently radiosensitize surviving hypoxic cancer cells. Measuring tumor reoxygenation between radiation fractions could conceivably provide an early biomarker of treatment response. However, the relationship between tumor reoxygenation and local control is not well understood. We used noninvasive optical fiber-based diffuse reflectance spectroscopy to monitor radiation-induced changes in hemoglobin oxygen saturation (sO
    MeSH term(s) Animals ; Biomarkers ; Cell Line, Tumor ; Disease Models, Animal ; Dose Fractionation, Radiation ; Dose-Response Relationship, Radiation ; Humans ; Immunohistochemistry ; Mice ; Neoplasms/diagnostic imaging ; Neoplasms/metabolism ; Neoplasms/radiotherapy ; Optical Imaging ; Oxidation-Reduction/radiation effects ; Oxygen/analysis ; Oxygen/metabolism ; Oxygen Consumption/radiation effects ; Radiation ; Radiation Tolerance ; Radiotherapy ; Spectrum Analysis/methods ; Xenograft Model Antitumor Assays
    Chemical Substances Biomarkers ; Oxygen (S88TT14065)
    Language English
    Publishing date 2020-11-18
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1483840-0
    ISSN 1476-5586 ; 1522-8002
    ISSN (online) 1476-5586
    ISSN 1522-8002
    DOI 10.1016/j.neo.2020.11.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Galectins as Molecular Targets for Therapeutic Intervention.

    Dings, Ruud P M / Miller, Michelle C / Griffin, Robert J / Mayo, Kevin H

    International journal of molecular sciences

    2018  Volume 19, Issue 3

    Abstract: Galectins are a family of small, highly conserved, molecular effectors that mediate various biological processes, including chemotaxis and angiogenesis, and that function by interacting with various cell surface glycoconjugates, usually targeting β- ... ...

    Abstract Galectins are a family of small, highly conserved, molecular effectors that mediate various biological processes, including chemotaxis and angiogenesis, and that function by interacting with various cell surface glycoconjugates, usually targeting β-galactoside epitopes. Because of their significant involvement in various biological functions and pathologies, galectins have become a focus of therapeutic discovery for clinical intervention against cancer, among other pathological disorders. In this review, we focus on understanding galectin structure-function relationships, their mechanisms of action on the molecular level, and targeting them for therapeutic intervention against cancer.
    MeSH term(s) Animals ; Carbohydrates/chemistry ; Drug Therapy, Combination ; Galectins/chemistry ; Galectins/metabolism ; Humans ; Molecular Targeted Therapy
    Chemical Substances Carbohydrates ; Galectins
    Language English
    Publishing date 2018-03-19
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms19030905
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models

    Nathan A. Koonce / Robert J. Griffin / Ruud P. M. Dings

    International Journal of Molecular Sciences, Vol 18, Iss 12, p

    2017  Volume 2671

    Abstract: Galectin-1 is a hypoxia-regulated protein and a prognostic marker in head and neck squamous cell carcinomas (HNSCC). Here we assessed the ability of non-peptidic galectin-1 inhibitor OTX008 to improve tumor oxygenation levels via tumor vessel ... ...

    Abstract Galectin-1 is a hypoxia-regulated protein and a prognostic marker in head and neck squamous cell carcinomas (HNSCC). Here we assessed the ability of non-peptidic galectin-1 inhibitor OTX008 to improve tumor oxygenation levels via tumor vessel normalization as well as tumor growth inhibition in two human HNSCC tumor models, the human laryngeal squamous carcinoma SQ20B and the human epithelial type 2 HEp-2. Tumor-bearing mice were treated with OTX008, Anginex, or Avastin and oxygen levels were determined by fiber-optics and molecular marker pimonidazole binding. Immuno-fluorescence was used to determine vessel normalization status. Continued OTX008 treatment caused a transient reoxygenation in SQ20B tumors peaking on day 14, while a steady increase in tumor oxygenation was observed over 21 days in the HEp-2 model. A >50% decrease in immunohistochemical staining for tumor hypoxia verified the oxygenation data measured using a partial pressure of oxygen (pO2) probe. Additionally, OTX008 induced tumor vessel normalization as tumor pericyte coverage increased by approximately 40% without inducing any toxicity. Moreover, OTX008 inhibited tumor growth as effectively as Anginex and Avastin, except in the HEp-2 model where Avastin was found to suspend tumor growth. Galectin-1 inhibitor OTX008 transiently increased overall tumor oxygenation via vessel normalization to various degrees in both HNSCC models. These findings suggest that targeting galectin-1—e.g., by OTX008—may be an effective approach to treat cancer patients as stand-alone therapy or in combination with other standards of care.
    Keywords galectin-1 inhibitor ; OTX008 ; Avastin ; Anginex ; hypoxia ; pimonidazole ; vessel normalization ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Language English
    Publishing date 2017-12-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Dendritic cell biocompatibility of ether-based urethane films.

    Safina, Ingrid / Alghazali, Karrer M / Childress, Luke / Griffin, Christopher / Hashoosh, Ahmed / Kannarpady, Ganesh / Watanabe, Fumiya / Bourdo, Shawn E / Dings, Ruud P M / Biris, Alexandru S / Vang, Kieng Bao

    Journal of applied toxicology : JAT

    2021  Volume 41, Issue 9, Page(s) 1456–1466

    Abstract: The use of synthetic materials for biomedical applications is ever expanding. One of the major requirements for these materials is biocompatibility, which includes prevention of immune system responses. Due to the inherent complexity of their structural ... ...

    Abstract The use of synthetic materials for biomedical applications is ever expanding. One of the major requirements for these materials is biocompatibility, which includes prevention of immune system responses. Due to the inherent complexity of their structural composition, the polyurethane (PU) family of polymers is being used in a variety of medical applications, from soft and hard tissue scaffolds to intricate coatings on implantable devices. Herein, we investigated whether two polymer materials, D3 and D7, induced an immune response, measured by their effects on a dendritic cell (DC) line, JAWS II. Using a lactate dehydrogenase cytotoxicity assay and Annexin V/PI staining, we found that the PU materials did not induce cytotoxicity in DC cells. Using confocal microscopy, we also showed that the materials did not induce activation or maturation, as compared to positive controls. This was confirmed by looking at various markers, CD80, CD86, MHC class I, and MHC class II, via flow cytometry. Overall, the results indicated that the investigated PU films are biocompatible in terms of immunotoxicology and immunogenicity and show great promise for use in regenerative medicine.
    MeSH term(s) Animals ; Biocompatible Materials ; Bone Marrow Cells/drug effects ; Cell Survival/drug effects ; Dendritic Cells/drug effects ; Dendritic Cells/immunology ; Ethers ; Materials Testing/methods ; Mice ; Mice, Inbred C57BL ; Nanostructures/toxicity ; Polyurethanes/pharmacology ; Regenerative Medicine ; Tissue Engineering ; Tissue Scaffolds
    Chemical Substances Biocompatible Materials ; Ethers ; Polyurethanes
    Language English
    Publishing date 2021-01-08
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 604625-3
    ISSN 1099-1263 ; 0260-437X
    ISSN (online) 1099-1263
    ISSN 0260-437X
    DOI 10.1002/jat.4136
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top